• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL Joins Veristat

We are excited to inform that SFL was acquired by Veristat, combining the strengths of two organizations with a shared commitment to quality and scientific integrity. SFL chose to join Veristat to capitalize on our common abilities to solve complex drug and medical product challenges with scientific-minded thinking to support our clients’ ongoing and future needs.

The combination of our teams further supports our ability to positively influence the scientific progress, regulatory assessment and launch success of treatments for patients with difficult-to-treat diseases and conditions. Veristat brings more than 27 years’ experience in clinical trial planning and execution, with deep expertise in novel therapeutics. They offer bold thinking and a comprehensive range of services to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval and commercialization.

Veristat expands SFL’s ability to work closely with the FDA and provides a more substantial range of clinical development services such as global clinical operations, biostatistics and programming, medical affairs, and extended regulatory and medical writing support.

SFL’s founder and CEO, Shayesteh Fürst-Ladani, will continue her role as Head of the SFL Group and play a leadership role within Veristat, available to support our clients’ program and business needs.

See here the press release about the combination of SFL and Veristat.

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top